Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MSNovember 28, 2017Multiple Sclerosis
Siponimod Improves MRI Outcomes in Patients With Secondary Progressive MSNovember 22, 2017Multiple Sclerosis
Durable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-UpNovember 2, 2017Multiple Sclerosis
Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MSOctober 25, 2017Multiple Sclerosis
